MDD(Mild Cognitive Impairment Delirium Dementia) Cohort

  • STATUS
    Recruiting
  • End date
    Dec 31, 2023
  • participants needed
    163
  • sponsor
    Keimyung University Dongsan Medical Center
Updated on 25 January 2022
cognitive impairment
dementia
mini-mental state examination
mild cognitive impairment
mental state examination
cognitive assessment

Summary

  • Identify the degree of delirium in subjects with mild cognitive impairment and find the risk factors of delirium. Mortality, hospital stay, and medical expenses are analyzed as clinical consequences related to delirium incidence.
    • Dementia conversion rate and conversion period of subjects with mild cognitive impairment with delirium and it identifies the effect of delirium on dementia conversion.
    • Develop an AI(Artificial intelligence) algorithm for predicting dementia transition in subjects with mild cognitive impairment based on the research results of the 1st, 2nd, and 3rd years.

Details
Condition Delirium, Mild Cognitive Impairment, Dementia
Treatment Delirium assessment using S-CAM
Clinical Study IdentifierNCT05113446
SponsorKeimyung University Dongsan Medical Center
Last Modified on25 January 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients 65 years of age or older who are admitted to a LTC
Patients diagnosed with mild cognitive impairment by doctors
Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination

Exclusion Criteria

Patients unable to measure the delirium assessment tool, The Short Confusion Assessment Methods (S-CAM) (Inouye, 2014) due to severe vision and hearing problems
Patients with serious psychiatric or neurological diagnosis,Patients who expire or were transferred on the day of admission -
Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note